The DOI matches its Crossref record; 224 of the 224 references it cites were found in a registry or an index.
Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases
Open accessAbstract
Hypoxia-inducible factors (HIFs) are stabilized during adverse inflammatory processes associated with disorders such as inflammatory bowel disease, pathogen infection and acute lung injury, as well as during ischaemia–reperfusion injury. HIF stabilization and hypoxia-induced changes in gene expression have a profound impact on the inflamed tissue microenvironment and on disease outcomes. Although the mechanism that initiates HIF stabilization may vary, the final molecular steps that control HIF stabilization converge on a set of oxygen-sensing prolyl hydroxylases (PHDs) that mark HIFs for proteasomal degradation. PHDs are therefore promising therapeutic targets. In this Review, we discuss the emerging potential and associated challenges of targeting the PHD–HIF pathway for the treatment of inflammatory and ischaemic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–224 of 224
The Antimicrobial Peptide DEFB1 Is Associated with Caries
Öztürk, A., Famili, P., & Vieira, A. R. (2010) · Journal of Dental Research · doi:10.1177/0022034510364491 · Cited by 98
Oxygen-Independent Stabilization of Hypoxia Inducible Factor (HIF)-1 during RSV Infection
Haeberle, H. A., Dürrstein, C., Rosenberger, P., Hosakote, Y. M., Kuhlicke, J., Kempf, V. A. J., Garofalo, R. P., & Eltzschig, H. K. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003352 · Cited by 91
Self-citationAntiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation
Khoury, J., Ibla, J. C., Neish, A. S., & Colgan, S. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30049 · Cited by 82
Self-citationYeo, E.-J., Ryu, J., Cho, Y.-S., Chun, Y., Huang, E. L., Kim, M., & Park, J. (2005) · Blood · doi:10.1182/blood-2005-06-2564 · Cited by 81
Asikainen, T. M., Chang, L.-Y., Coalson, J. J., Schneider, B. K., Waleh, N. S., Ikegami, M., Shannon, J. M., Winter, V. T., Grubb, P. H., Clyman, R. I., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5887fje · Cited by 79
Casanello, P. C., Torres, A., Sanhueza, F., González, M., Farías, M., Gallardo, V., Pastor‐Anglada, M., Martín, R. S., & Sobrevía, L. (2005) · Circulation Research · doi:10.1161/01.res.0000172568.49367.f8 · Cited by 79
Paneth Cell–Mediated Multiorgan Dysfunction after Acute Kidney Injury
Park, S. W., Kim, M., Kim, J. Y., Ham, A., Brown, K. M., Mori–Akiyama, Y., Ouellette, A. J., D’Agati, V. D., & Lee, H. T. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200581 · Cited by 78
Interplay of Hypoxia and A2B Adenosine Receptors in Tissue Protection
Koeppen, M., Eckle, T. D. L. G., & Eltzschig, H. K. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385526-8.00006-0 · Cited by 76
Self-citationHypoxia Modulates Infection of Epithelial Cells by Pseudomonas aeruginosa
Schaible, B., McClean, S., Selfridge, A. C., Broquet, A. H., Asehnoune, K., Taylor, C. T., & Schaffer, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056491 · Cited by 75
Puppo, M., Battaglia, F., Ottaviano, C., Delfino, S., Ribatti, D., Varesio, L., & Bosco, M. C. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2059 · Cited by 74
Design and synthesis of a series of novel pyrazolopyridines as HIF 1-α prolyl hydroxylase inhibitors
Warshakoon, N. C., Wu, S., Boyer, A. S., Kawamoto, R. M., Renock, S., Xu, K., Pokross, M. E., Evdokimov, A. G., Zhou, S., Winter, C., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.08.017 · Cited by 74
Association of beta-defensin 1 single nucleotide polymorphisms with Crohn's disease
Kocsis, Á. K., Lakatos, P. L., Somogyvári, F., Fuszek, P., Papp, J., Fischer, S., Szamosi, T., Lakatos, L., Kovács, Á., Hofner, P., et al. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701682615 · Cited by 74
Dengler, V., Downey, G. P., Tuder, R. M., Eltzschig, H. K., & Schmidt, E. P. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0472tr · Cited by 67
Self-citationA 3′ UTR transition within DEFB1 is associated with chronic and aggressive periodontitis
Schäefer, A. S., Richter, G. M., Nothnagel, M., Laine, M. L., Rühling, A., Schäfer, C., Cordes, N., Noack, B., Folwaczny, M., Glas, J., et al. (2009) · Genes and Immunity · doi:10.1038/gene.2009.75 · Cited by 67
Cancer Therapeutic Agents Targeting Hypoxia-Inducible Factor-1
Wang, R., Zhou, S.-S., & Li, S. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796391606 · Cited by 66
Choi, S., Choi, K.-O., Park, Y.-K., Cho, H.-J., Yang, E. G., & Park, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603913200 · Cited by 61
Neddylation-Induced Conformational Control Regulates Cullin RING Ligase Activity In Vivo
Boh, B. K., Smith, P. G., & Hagen, T. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.023 · Cited by 59
New Anemia Therapies: Translating Novel Strategies From Bench to Bedside
Macdougall, I. C. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.11.013 · Cited by 58
Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation
Eltzschig, H. K., Rivera–Nieves, J., & Colgan, S. P. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903241666 · Cited by 57
Self-citationChronic granulomatous disease caused by a deficiency in p47phox mimicking Crohn’s disease
Huang, J. S., Noack, D., Rae, J., Ellis, B. A., Newbury, R., Pong, A. L., Lavine, J. E., Curnutte, J. T., & Bastian, J. F. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00292-7 · Cited by 53
Ehrentraut, S., Kominsky, D. J., Glover, L. E., Campbell, E. L., Kelly, C. J., Bowers, B., Bayless, A. J., & Colgan, S. P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202041 · Cited by 50
Self-citationChoukèr, A., Ohta, A., Martignoni, A., Lukashev, D. E., Zacharia, L. C., Jackson, E. K., Schnermann, J. B., Ward, J. M., Kaufmann, I., Klaunberg, B. A., et al. (2012) · Transplantation · doi:10.1097/tp.0b013e31826a9a46 · Cited by 47
Mikus, P., & Zundel, W. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.03.002 · Cited by 23
Vasodilator Phosphostimulated Protein (VASP) Protects Endothelial Barrier Function During Hypoxia
Schmit, M. A., Mirakaj, V., Stangassinger, M., König, K., Köhler, D., & Rosenberger, P. (2011) · Inflammation · doi:10.1007/s10753-011-9347-z · Cited by 16
Cited by
Zheng, L., Kelly, C. J., & Colgan, S. P. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00191.2015 · Cited by 499
Self-citationCircadian rhythm as a therapeutic target
Ruan, W., Yuan, X., & Eltzschig, H. K. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00109-w · Cited by 486
Self-citationGupta, N., & Wish, J. B. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.12.011 · Cited by 444
Hypoxia signaling in human diseases and therapeutic targets
Lee, J. W., Ko, J., Ju, C., & Eltzschig, H. K. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0235-1 · Cited by 384
Self-citationStructural integration in hypoxia-inducible factors
Wu, D., Potluri, N., Lu, J., Kim, Y., & Rastinejad, F. (2015) · Nature · doi:10.1038/nature14883 · Cited by 346
Metadata
- Authors
- Eltzschig, H. K., Bratton, D. L., & Colgan, S. P.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2014-10-31
- Volume
- 13
- Issue
- 11
- Pages
- 852-869
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2039765075
- Cited by
- 366
- References
- 224
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.